Works by Ansell, Stephen M.

Results: 215
    1

    Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01322-9
    By:
    • Atallah-Yunes, Suheil Albert;
    • Rees, Matthew J.;
    • Mwangi, Raphael;
    • Kuchler, Robyn L.;
    • Alnughmush, Ahmed;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Villasboas Bisneto, Jose C.;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    2

    Long‐term outcome of immunologic autograft engineering.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 488, doi. 10.1002/jha2.404
    By:
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Paludo, Jonas;
    • Markovic, Svetomir N.
    Publication type:
    Article
    3
    4
    5
    6

    Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.

    Published in:
    European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
    By:
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Elliott, Michelle A.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Porrata, Luis F.;
    • Johnston, Patrick A.;
    • Afessa, Bekele;
    • Bryce, Alan;
    • Kyle, Robert A.;
    • Gertz, Morie A.
    Publication type:
    Article
    7
    8
    9

    A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-44
    By:
    • de Vos, Sven;
    • Forero-Torres, Andres;
    • Ansell, Stephen M.;
    • Kahl, Brad;
    • Cheson, Bruce D.;
    • Bartlett, Nancy L.;
    • Furman, Richard R.;
    • Winter, Jane N.;
    • Kaplan, Henry;
    • Timmerman, John;
    • Whiting, Nancy C.;
    • Drachman, Jonathan G.;
    • Advani, Ranjana
    Publication type:
    Article
    10
    11
    12
    13

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    14

    Peak absolute lymphocyte count after CAR‐T infusion predicts clinical response in aggressive lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 7, p. E241, doi. 10.1002/ajh.26561
    By:
    • Bansal, Radhika;
    • Novo, Mattia;
    • Al Saleh, Abdullah S.;
    • Guerrico, Anatilde Gonzalez;
    • Zhang, Henan;
    • Shao, Zuoyi;
    • Babadi, Elham;
    • Martinez, Kodi E.;
    • McCoy, Gabrielle A.;
    • Hathcock, Matthew A.;
    • Khurana, Arushi;
    • Bennani, Nabila Nora;
    • Paludo, Jonas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Lin, Yi
    Publication type:
    Article
    15
    16
    17

    Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
    By:
    • Khurana, Arushi;
    • Hathcock, Matthew;
    • Habermann, Thomas M.;
    • Al Saleh, Abdullah S.;
    • Gandhi, Sangeetha;
    • Truong, Tuan;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Johnston, Patrick B.;
    • Micallef, Ivana;
    • Lin, Yi
    Publication type:
    Article
    18

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    19
    20
    21

    Prevalence, clinical characteristics and prognosis of EBV‐positive follicular lymphoma.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 2, p. E62, doi. 10.1002/ajh.25357
    By:
    • Mackrides, Nicholas;
    • Chapman, Jennifer;
    • Larson, Melissa C.;
    • Ramos, Juan C.;
    • Toomey, Ngoc;
    • Lin, Pei;
    • Maurer, Matthew J.;
    • Rafaelle, Myra;
    • Tan, Yaohong;
    • Ikpatt, Offiong;
    • Syrbu, Sergei;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Lossos, Izidore S.;
    • Cerhan, James R.;
    • Vega, Francisco
    Publication type:
    Article
    22

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    23
    24

    Reply to Castillo et al.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
    By:
    • Abeykoon, Jithma P.;
    • King, Rebecca;
    • Ansell, Stephen M.;
    • Rajkumar, S. Vincent;
    • Paludo, Jonas;
    • Kyle, Robert A.;
    • Kumar, Shaji;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    25

    <italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
    By:
    • Abeykoon, Jithma P.;
    • Paludo, Jonas;
    • King, Rebecca L.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • LaPlant, Betsy R.;
    • Halvorson, Alese E.;
    • Gonsalves, Wilson I.;
    • Dingli, David;
    • Fang, Hong;
    • Rajkumar, S. Vincent;
    • Lacy, Martha Q.;
    • He, Rong;
    • Kourelis, Taxiarchis;
    • Reeder, Craig B.;
    • Novak, Anne J.;
    • McPhail, Ellen D.;
    • Viswanatha, David S.;
    • Witzig, Thomas E.;
    • Go, Ronald S.
    Publication type:
    Article
    26

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    27

    Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
    By:
    • Maurer, Matthew J.;
    • Bachy, Emmanuel;
    • Ghesquières, Hervé;
    • Ansell, Stephen M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Inwards, David J.;
    • Allmer, Cristine;
    • Chassagne-Clément, Catherine;
    • Nicolas-Virelizier, Emmanuelle;
    • Sebban, Catherine;
    • Lebras, Laure;
    • Sarkozy, Clementine;
    • Macon, William R.;
    • Feldman, Andrew L.;
    • Syrbu, Sergei I.;
    • Traverse-Glehan, Alexandra;
    • Coiffier, Bertrand;
    • Slager, Susan L.;
    • Weiner, George J.
    Publication type:
    Article
    28
    29
    30
    31
    32

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    33
    34

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article
    42
    43
    44
    45

    Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01173-w
    By:
    • Bhardwaj, Vaishali;
    • Yang, Zhi-Zhang;
    • Jalali, Shahrzad;
    • Villasboas, Jose C.;
    • Mudappathi, Rekha;
    • Wang, Junwen;
    • Mukherjee, Prithviraj;
    • Paludo, Jonas;
    • Tang, Xinyi;
    • Kim, Hyo Jin;
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Novak, Anne J.;
    • Mondello, Patrizia;
    • Ansell, Stephen M.
    Publication type:
    Article
    46

    DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
    By:
    • Hopper, Melissa A.;
    • Dropik, Abigail R.;
    • Walker, Janek S.;
    • Novak, Joseph P.;
    • Laverty, Miranda S.;
    • Manske, Michelle K.;
    • Wu, Xiaosheng;
    • Wenzl, Kerstin;
    • Krull, Jordan E.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Yang, Zhi-Zhang;
    • Del Busso, Miles D.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Rimsza, Lisa M.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Jevremovic, Dragan
    Publication type:
    Article
    47

    Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
    By:
    • Bock, Allison M.;
    • Gile, Jennifer J.;
    • Larson, Melissa C.;
    • Poonsombudlert, Kittika;
    • Tawfiq, Reema K.;
    • Maliske, Seth;
    • Maurer, Matthew J.;
    • Kabat, Brian F.;
    • Paludo, Jonas;
    • Inwards, David J.;
    • Ayyappan, Sabarish;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Cerhan, James R.;
    • Farooq, Umar;
    • Wang, Yucai
    Publication type:
    Article
    48

    T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
    By:
    • Yang, Zhi-Zhang;
    • Kim, Hyo Jin;
    • Wu, Hongyan;
    • Tang, Xinyi;
    • Yu, Yue;
    • Krull, Jordan;
    • Larson, Daniel P.;
    • Moore, Raymond M.;
    • Maurer, Matthew J.;
    • Pavelko, Kevin D.;
    • Jalali, Shahrzad;
    • Pritchett, Joshua C.;
    • Mudappathi, Rekha;
    • Wang, Junwen;
    • Villasboas, Jose C.;
    • Mondello, Patrizia;
    • Novak, Anne J.;
    • Ansell, Stephen M.
    Publication type:
    Article
    49

    Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00895-7
    By:
    • Breen, William G.;
    • Young, Jason R.;
    • Hathcock, Matthew A.;
    • Kowalchuk, Roman O.;
    • Thorpe, Matthew P.;
    • Bansal, Radhika;
    • Khurana, Arushi;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Bisneto, Jose Villasboas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Peterson, Jennifer L.;
    • Johnston, Patrick B.;
    • Lester, Scott C.;
    • Lin, Yi
    Publication type:
    Article
    50

    Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
    By:
    • Acosta-Medina, Aldo A.;
    • Johnson, Isla McKerrow;
    • Bansal, Radhika;
    • Hathcock, Matthew;
    • Kenderian, Saad J.;
    • Durani, Urshila;
    • Khurana, Arushi;
    • Wang, Yucai;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Johnston, Patrick B.;
    • Ansell, Stephen M.;
    • Lin, Yi;
    • Alkhateeb, Hassan B.
    Publication type:
    Article